Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities.
about
Hyaluronan: A Mediator of Islet Dysfunction and Destruction in Diabetes?Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function.A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatHigh glucose predisposes gene expression and ERK phosphorylation to apoptosis and impaired glucose-stimulated insulin secretion via the cytoskeletonDecreased serum CA19-9 is associated with improvement of insulin resistance and metabolic control in patients with obesity and type 2 diabetes after Roux-en-Y gastric bypass.Low serum amylase in association with metabolic syndrome and diabetes: A community-based studyPericytopathy: oxidative stress and impaired cellular longevity in the pancreas and skeletal muscle in metabolic syndrome and type 2 diabetes.The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action.The islet-acinar axis of the pancreas: more than just insulin.Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.Exocrine pancreatic insufficiency in diabetic patients: prevalence, mechanisms, and treatment.The islet endothelial cell: a novel contributor to beta cell secretory dysfunction in diabetes.Exploring inter-organ crosstalk to uncover mechanisms that regulate β-cell function and mass.[Exocrine pancreatic insufficiency and diabetes mellitus].Activated pancreatic stellate cells can impair pancreatic islet function in mice.Human Islets Have Fewer Blood Vessels than Mouse Islets and the Density of Islet Vascular Structures Is Increased in Type 2 DiabetesReversible high blood CEA and CA19-9 concentrations in a diabetic patient.The evaluation of serum amylase in the patients of type 2 diabetes mellitus, with a possible correlation with the pancreatic functions.Functional and association analysis of an Amerindian-derived population-specific p.(Thr280Met) variant in RBPJL, a component of the PTF1 complex.Bottom-up proteomics analysis of the secretome of murine islets of Langerhans in elevated glucose levels.Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels.
P2860
Q26799151-DD07D316-4D74-4737-B2C1-2909F3DE4257Q33711031-6D936195-E343-4EC3-8408-BD08DB2B819AQ33820943-543BB245-BE7E-4EA9-8D1E-692FDEC84489Q34425147-2E45D5AD-DDFD-4E2C-80A2-D0943F5A87C3Q34523725-A874C977-018E-4BF9-AE7B-7C9AA26EE0A9Q35009097-994F957F-EDFF-4828-B619-60B273A9CB53Q35157945-536CDD30-2F66-439D-AB3D-939A72A6BD95Q36003362-6362601A-C21C-412A-BB1D-07B340C9B413Q37731773-F177D53B-E046-42FF-906D-8A70ABE6F492Q38354900-F9455888-67B9-4053-BB00-E8366336DDF5Q38429521-2A49A4DA-46B7-4D6C-AC3F-C4A784C707C9Q38843326-1C91E654-E398-4353-B4EE-DAA4DBE42EC2Q38907710-C6F17DF1-64E9-4B12-9175-C4A85AD4DFC6Q40814432-F461A698-8C3F-4D3C-A25E-B1A0F407A979Q41992472-CE03913F-2875-4EBF-8F64-0B882DB09A34Q42035979-53B47A33-41BF-4712-94DB-EC49239B273DQ42405453-F5DDBBAD-EBCB-46FD-B8F7-4FF45ACBABC5Q42563010-8C7F8FEB-7DD6-494D-BFA2-F4E34E015D83Q47231163-579E5EF0-5FB2-4D7C-8308-5343600721C6Q50235117-79651DCA-71EB-4767-94F0-01E0D78856CFQ50314975-1E569C41-CDBE-4BB5-9DA7-DDE067F290F2Q51315812-62BA3614-1C35-4833-8033-FAD8341D92EA
P2860
Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Attenuation of endocrine-exocr ...... ultrastructural abnormalities.
@en
Attenuation of endocrine-exocr ...... ultrastructural abnormalities.
@nl
type
label
Attenuation of endocrine-exocr ...... ultrastructural abnormalities.
@en
Attenuation of endocrine-exocr ...... ultrastructural abnormalities.
@nl
prefLabel
Attenuation of endocrine-exocr ...... ultrastructural abnormalities.
@en
Attenuation of endocrine-exocr ...... ultrastructural abnormalities.
@nl
P2093
P2860
P1476
Attenuation of endocrine-exocr ...... ultrastructural abnormalities.
@en
P2093
Adam Whaley-Connell
Deepa Gupta
James R Sowers
Javad Habibi
Kamlesh Patel
Melvin R Hayden
Seema S Tekwani
P2860
P304
P356
10.1111/J.1559-4572.2008.00024.X
P577
2008-01-01T00:00:00Z